FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:2006-2008 December 23, 1999 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Milgrom, H. PubMed Citation

Over the past 10 years there have been striking improvements in the treatment of asthma, largely as a result of the earlier and more widespread use of inhaled corticosteroids. The development of new treatments for asthma has proved difficult, although several immunologic approaches are undergoing preclinical and clinical assessment.¹ Antileukotrienes are the only new class of drugs to treat asthma that have been introduced in the past 25 years, but their efficacy is somewhat limited and unpredictable, as compared with that of inhaled corticosteroids.

Mild asthma can be controlled in most patients by relatively low doses of inhaled corticosteroids, and . . . [Full Text of this Article]

References

This article has been cited by other articles:

• (2005). Immunotherapy. CMAJ 173: S46-S50 [Full Text]  
• Hanf, G., Noga, O., O'Connor, A., Kunkel, G. (2004). Omalizumab inhibits allergen challenge-induced nasal response. Eur Respir J 23: 414-419 [Abstract] [Full Text]  
• Drewe, E, Powell, R J (2002). Clinically useful monoclonal antibodies in treatment. J. Clin. Pathol. 55: 81-85 [Abstract] [Full Text]  
• Crystal, R. G. (2001). Research Opportunities and Advances in Lung Disease. JAMA 285: 612-618 [Abstract] [Full Text]  
• Salvi, S. S., Babu, K. S., Milgrom, H., Fick, R. B., Metzger, W. J. (2000). Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody. NEJM 342: 1292-1293 [Full Text]